High-throughput Proteomics
 
Solutions in the Post Genomic Age
      SERVICES      TECHNOLOGIES      DISCOVERIES      PUBLICATIONS
HOME      CAREERS      CONTACT US      
First to array the entire SARS genome encoded peptides and to map SARS-specific epitopes.

Discovered a series of candidate peptides effectively blocking P-Glycoprotein and increasing intracellular concentration of chemotherapeutics.

Discovered a series of candidate peptides effectivley inhibiting reverse transcriptase. The encoded DNA transfected cells inhibited HIV viral replication.

Mapped tau-tau specific binding regions on tau protein, which can become targets for developing drugs treating Alzheimer's disease.

Discovered a peptide which inhibits carboxypeptidase R activity and dramatically reduces fibrinolysis time when combined with tissue plasminogen activator for treating thrombosis.

High throughput sera screening in identifying biomarkers for early cancer diagnosis.

High throughput sample screening in identifying biological fingerprints for the development of quality control tests and detection of hazardous substances.

Generation of peptide antibody mimetics to HER2 for treatment of breast cancer.

Discovery of peptides inhibiting tyrosinase and melanin synthesis, which can be developed into a skin pigment lightening product.

Discovery of peptides inhibiting protein activity in presynaptic neurons and release of acetylcholine.

 
 
 
© Copyright 2004 PepMetric Technologies Inc.     | Terms and Conditions     | Feedback